Loading…
Academic Journal
Green synthesized Polyscias fulva silver nanoparticles ameliorate uterine fibroids in female Wistar Albino rats.
Kiyimba, Kenedy, Ahmed, Ayaz, Choudhary, Muhammad Iqbal, Rehman, Khadija, Hasan, Syed Mehmood, Jabbar, Abdul, Obakiro, Samuel Baker, Shah, Muhammad Raza, Munyendo, Were Lincoln, Guantai, Eric M., Gavamukulya, Yahaya
PLoS ONE. 5/9/2025, Vol. 20 Issue 5, p1-19. 19p.
Saved in:
Title | Green synthesized Polyscias fulva silver nanoparticles ameliorate uterine fibroids in female Wistar Albino rats. |
---|---|
Authors | Kiyimba, Kenedy, Ahmed, Ayaz, Choudhary, Muhammad Iqbal, Rehman, Khadija, Hasan, Syed Mehmood, Jabbar, Abdul, Obakiro, Samuel Baker, Shah, Muhammad Raza, Munyendo, Were Lincoln, Guantai, Eric M., Gavamukulya, Yahaya |
Source |
PLoS ONE. 5/9/2025, Vol. 20 Issue 5, p1-19. 19p.
|
Abstract |
Uterine fibroids affect a substantial proportion of women in their reproductive age. Despite their effectiveness, surgical options such as hysterectomy are invasive, costly, and associated with recurrences. Pharmacological treatments are non-curative, only alleviate symptoms, and associated with adverse effects. Polyscias fulva (Araliaceae) is traditionally used to manage uterine fibroids in East Africa. In this study we synthesized Polyscias fulva silver nanoparticles (PFAgNPs), evaluated their toxicity and activity against monosodium glutamate (MSG)-induced uterine fibroids in Wistar albino rats. The UV-visible spectroscopy showed maximal absorbance at 425 nm with adequate stability at varying temperatures, pH and storage conditions. Dynamic light scattering (DLS) analysis revealed an average hydrodynamic size of 107.4 d.nm, polydispersity index of 0.264, and zeta potential of -18.3 mV. X-ray diffraction (XRD) confirmed the crystalline nature of PFAgNPs with an average size of 25 nm while scanning electron microscopy (SEM) showed a spherical shape with an average size of 35 nm. The PFAgNPs caused lethargy, hyperventilation, and hyperactivity at a dose of 300 mg/kg BW, whereas 2000 mg/kg caused severe toxicity, resulting in death in acute toxicity testing. The no observed adverse effect level was 50 mg/kgBW, the lowest observed adverse effect level was 100 mg/kgBW, and median lethal dose (LD50) was 1000 mg/kg. The PFAgNPs significantly decreased (P < 0.05) serum proteins, cholesterol, estrogen and progesterone alongside preservation of the histoarchitecture of the uterus. Further research is needed to investigate the clinical safety of PFAgNPs in managing uterine fibroids. [ABSTRACT FROM AUTHOR]
|
Subject Terms | |
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
|
|
This result is restricted to LU affiliated users only.
Sign in or register for an institutional account to gain full access, if eligible. |